And it could happen in five years or less.
News & Analysis: Amgen
Few industries were spared from layoffs in 2019.
Which stock wins in a match-up between these two healthcare giants?
But the big biotech isn't a happy camper about its contribution.
These stocks could be great sources of dividend income for many years to come.
Both of these drugmakers have solid portfolios and treatment pipelines, but savvy investors will find good reason to favor one over the other.
Which stock wins in this battle of two big biotechs?
Biotech can be a risky sector for those interested in healthcare stocks, but Amgen has found a way to manage the risk and reap the rewards.
The biotech titan is poised for another strong year in 2020.
Which stock wins in a battle between these two big biotechs?